Unicity International, founded in 1903 and headquartered in Orem, Utah, (United States) launched World’s first ever Genomeceutical™ (gene controlling) range of products to India.
Human DNA makes every individual unique. It contains the biological code that defines every single protein in the body. DNA undergoes a process called transcription or gene expression that creates a “messenger” molecule, telling the body to make a specific protein. Each protein that is made in the body carries out a crucial function that keeps us healthy. As the body ages, DNA transcription may get adversely affected and the proteins may stop working properly. Unicity therefore uses advanced Genomecuitical™ technology in its products to support proper gene expression, which helps maintain healthy body function at their most basic levels.
Genomeceutical™is a ground-breaking, patent-pending, technology whereby certain secondary metabolites found in nature can help maintain the gene response whenever needed by the body and help maintain overall metabolic health. Unicity is currently researching an extensive range of products by leveraging this technology.
Speaking on the launch of Unicity’s Neigene skin restoration system, Dr. Dan Gubler, Chief Scientific Officer, Unicity, said, “Beautiful skin starts with healthy cells. Neigene is designed using advanced, cell-targeted, healthy-aging technology. World over, the personal care industry is struggling to find sustainable solutions for skin protection from UV radiation and impact of lifestyle related stress. Unicity has researched the use of premium extracts that control gene response and produce collagen to such stimuli while not only preventing further degeneration but also accentuating effective skin restoration. We have pioneered this as our first Genomeceutical™ product. Research is underway to apply this technology to other areas of body care.”
Unicity International has a wide range of nutritional products worldwide. The company launched its India operations in 2010 and now with the launch of new generation range of Genomeceuticals™, it aims to create a premium and differentiated niche for itself in the personal care segment. The company plans to launch several new generation products in India over the next 2-3 years.